Scarica l'app Stockscreener
2.935
0.51%
-0.015
Precedente Chiudi:
$2.95
Aprire:
$2.97
Volume 24 ore:
2.44M
Relative Volume:
0.70
Capitalizzazione di mercato:
$778.20M
Reddito:
$194.75M
Utile/perdita netta:
$-51.26M
Rapporto P/E:
-10.48
EPS:
-0.28
Flusso di cassa netto:
$-23.38M
1 W Prestazione:
+1.56%
1M Prestazione:
+3.71%
6M Prestazione:
+54.47%
1 anno Prestazione:
+120.68%
Intervallo 1D:
$2.89
$3.10
Intervallo di 1 settimana:
$2.69
$3.10
Portata 52W:
$1.30
$4.0787
Akebia Therapeutics Inc Stock (AKBA) Company Profile
Nome
Akebia Therapeutics Inc
Settore
Telefono
617-871-2098
Indirizzo
245 FIRST STREET, CAMBRIDGE, MA
Confronta AKBA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AKBA
Akebia Therapeutics Inc
|
2.935 | 739.75M | 194.75M | -51.26M | -23.38M | -0.28 |
|
ZTS
Zoetis Inc
|
144.04 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.205 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.77 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.14 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Ripresa | H.C. Wainwright | Buy |
| 2025-04-28 | Iniziato | Leerink Partners | Outperform |
| 2025-04-01 | Iniziato | Jefferies | Buy |
| 2023-11-29 | Ripresa | BTIG Research | Buy |
| 2023-08-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-05-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-03-31 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-31 | Downgrade | Needham | Buy → Hold |
| 2022-03-31 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-03-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-29 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-11-14 | Reiterato | Needham | Buy |
| 2019-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2019-07-11 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-02 | Iniziato | JP Morgan | Overweight |
| 2019-03-20 | Iniziato | Citigroup | Neutral |
| 2018-09-07 | Ripresa | Morgan Stanley | Equal-Weight |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-06-06 | Reiterato | H.C. Wainwright | Buy |
| 2017-12-19 | Iniziato | Piper Jaffray | Overweight |
| 2017-12-07 | Iniziato | BTIG Research | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2017-07-10 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-27 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-27 | Reiterato | Needham | Buy |
| 2016-12-27 | Reiterato | H.C. Wainwright | Buy |
| 2016-12-20 | Reiterato | JMP Securities | Mkt Outperform |
| 2016-11-15 | Iniziato | Aegis Capital | Buy |
| 2016-09-29 | Iniziato | Brean Capital | Buy |
| 2016-03-16 | Reiterato | Needham | Buy |
| 2016-01-21 | Iniziato | Credit Suisse | Neutral |
Mostra tutto
Akebia Therapeutics Inc Borsa (AKBA) Ultime notizie
Is this a good reentry point in Akebia Therapeutics Inc.July 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Applying Elliott Wave Theory to Akebia Therapeutics Inc.2025 EndofYear Setup & Step-by-Step Swing Trade Plans - newser.com
Real time breakdown of Akebia Therapeutics Inc. stock performancePortfolio Risk Summary & Reliable Price Action Trade Plans - newser.com
How rising interest rates impact Akebia Therapeutics Inc. stock2025 Technical Overview & Free Risk Controlled Daily Trade Plans - newser.com
Should I hold or sell Akebia Therapeutics Inc. stock in 2025Earnings Overview Summary & Consistent Return Strategy Ideas - newser.com
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance
Order flow analysis tools used on Akebia Therapeutics Inc.Market Weekly Review & Daily Volume Surge Signals - newser.com
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Zacks Investment Research
What makes Akebia Therapeutics Inc. stock attractive to growth fundsJuly 2025 Action & Community Consensus Picks - newser.com
Applying chart zones and confluence areas to Akebia Therapeutics Inc.Quarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
What to expect from Akebia Therapeutics Inc. in the next 30 daysCPI Data & Fast Gaining Stock Strategy Reports - newser.com
Akebia Therapeutics Achieves Multibagger Status with 123.31% Stock Increase Over Past Year - Markets Mojo
Can technical indicators confirm Akebia Therapeutics Inc.’s reversalJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Potential 156% Upside Sparks Interest - DirectorsTalk Interviews
What machine learning models say about Akebia Therapeutics Inc.Quarterly Trade Summary & High Win Rate Trade Tips - newser.com
How Akebia Therapeutics Inc. stock performs in interest rate cycles2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Why Akebia Therapeutics Inc. (AX9) stock is a strong buy callQuarterly Portfolio Summary & Smart Allocation Stock Tips - newser.com
How Akebia Therapeutics Inc. stock reacts to inflationary pressuresTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-10-09 05:00:40 - newser.com
Can Akebia Therapeutics Inc. (AX9) stock resist broad market declinesQuarterly Trade Summary & AI Powered Market Entry Ideas - newser.com
How Akebia Therapeutics Inc. (AX9) stock moves in volatile trading sessions2025 Institutional Moves & Daily Chart Pattern Signals - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Akebia Therapeutics (NASDAQ:AKBA) - MarketBeat
Is Intellia Therapeutics (NTLA) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Profit Outlook - simplywall.st
What drives Akebia Therapeutics Inc stock priceInsider Buying Signals & Free Daily Market Summary and Trend Reports - earlytimes.in
Published on: 2025-10-03 06:28:34 - newser.com
Is Akebia Therapeutics Inc. stock poised for growthRate Hike & Weekly High Conviction Ideas - newser.com
Will Akebia Therapeutics Inc. (AX9) stock profit from AI boom2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Leading vs lagging indicators on Akebia Therapeutics Inc. performanceJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com
Akebia Therapeutics Inc Azioni (AKBA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):